Login to Your Account

FDA expands draft guidance on using the Animal Rule

By Mari Serebrov
Washington Editor

Monday, June 2, 2014
Instead of finalizing its draft guidance on human drug development under the Animal Rule, the FDA is revising the 6-year-old proposed recommendations. The new draft addresses a broader scope of issues, including vaccine development, cellular and gene therapy development, study conduct, and data quality and integrity.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription